1,3-dipropyl-8-cyclopentylxanthine and metoprolol

1,3-dipropyl-8-cyclopentylxanthine has been researched along with metoprolol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumann, G; Berndt, T; Felix, SB; Frank, TM; Harms, C; Kästner, R; Stangl, V1
Baumann, G; Buttke, K; Felix, SB; Frank, T; Harms, C; Muss, J; Stangl, K; Stangl, V1

Other Studies

2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and metoprolol

ArticleYear
Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion.
    Cardiovascular research, 1997, Volume: 35, Issue:1

    Topics: Adenosine Deaminase; Adrenergic beta-Antagonists; Animals; Autacoids; Catalase; Depression, Chemical; Female; Free Radical Scavengers; Guinea Pigs; Male; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Naphthalenes; Nitric Oxide Synthase; Nitroarginine; Perfusion; Phospholipases A; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyrones; Superoxide Dismutase; Theobromine; Xanthines

1997
Cardiodepressant mediators are released after myocardial ischaemia: modulation by catecholamines and adenosine.
    Acta physiologica Scandinavica, 1999, Volume: 165, Issue:4

    Topics: Adenosine; Adrenergic beta-Antagonists; Animals; Catecholamines; Chromatography, High Pressure Liquid; Guinea Pigs; In Vitro Techniques; Metoprolol; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Theobromine; Ventricular Function, Left; Xanthines

1999